Abstract
Little is known about bone mineral density (BMD) in patients with heroin addiction and subsequent methadone substitution. The goal of this study was to compare bone mass density of young HIV-negative women on long-term methadone treatment to a local group of young healthy women. Eleven women (aged 20–29) with previous heroin dependence and current methadone substitution (20–140 mg, median 60, daily) for 1.5–9 (median 3) years were compared to 30 healthy women (aged 20–28). Participants were examined with dual-energy X-ray absorptiometry of the lumbar spine (L2–L4), of the total proximal hip area, and of the femoral neck. Patients and controls had neither current nor lifetime underweight condition, had comparable ages at menarche, and did not differ significantly in current body mass index (21.9 ± 4.0, respectively, 20.5 ± 1.5 kg/m2) in spite of a largely unhealthy lifestyle (cigarette, alcohol, and cocaine consumption in patients). Patients’ total-hip parameters were marginally lower than those of controls (BMD P = 0.054, T score P = 0.049), whereas the femoral neck and lumbar spine parameters did not differ significantly between the two groups. Long-term methadone substitution in HIV-negative women seems to slightly affect bone mass density.
Similar content being viewed by others
References
Van Vort WB, Rubenstein M, Rose RP (1990) Osteoporosis with pathologic hip fractures in major depression. J Geriatr Psychiatry Neurol 3:10–12
Halbreich U, Palter S (1996) Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes. Schizophr Bull 22:447–454
Michelson D, Stratakis C, Hill L, Reynolds J, Galliven E, Chrousos G, Gold P (1996) Bone mineral density in women with depression. N Engl J Med 335:1176–1181
Kahl KG, Rudolf S, Stoeckelhuber BM, Dibbelt L, Gehl HB, Markhof K, Hohagen F, Schweiger U (2005) Bone mineral density, markers of bone turnover, and cytokines in young women with borderline personality disorder with and without comorbid major depressive disorder. Am J Psychiatry 162:168–174
Rigotti NA, Nussbaum SR, Herzog DB, Neer RM (1984) Osteoporosis in women with anorexia nervosa. N Engl J Med 311:1601–1606
Grinspoon S, Thomas E, Pitts S, Gross E, Mickley D, Miller K, Herzog D, Klibanski A (2000) Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med 133:790–794
Zipfel S, Seibel MJ, Lowe B, Beumont PJ, Kasperk C, Herzog W (2001) Osteoporosis in eating disorders: a follow-up study of patients with anorexia and bulimia nervosa. J Clin Endocrinol Metab 86:5227–5233
Milos G, Spindler A, Ruegsegger P, Hasler G, Schnyder U, Laib A, Gallo LM, Uebelhart D, Hauselmann H (2007) Does weight gain induce cortical and trabecular bone regain in anorexia nervosa? A two-year prospective study. Bone 41:869–874
Mehler PS, MacKenzie TD (2009) Treatment of osteopenia and osteoporosis in anorexia nervosa: a systematic review of the literature. Int J Eat Disord 42:195–201
Daniell HW (2004) Opioid osteoporosis. Arch Intern Med 164:338
Daniell HW (2002) Hypogonadism in men consuming sustained-action oral opioids. J Pain 3:377–384
Elhassan AM, Lindgren JU, Hultenby K, Bergstrom J, Adem A (1998) Methionine-enkephalin in bone and joint tissues. J Bone Miner Res 13:88–95
Perez-Castrillon JL, Olmos JM, Gomez JJ, Barrallo A, Riancho JA, Perera L, Valero C, Amado JA, Gonzalez-Macias J (2000) Expression of opioid receptors in osteoblast-like MG-63 cells, and effects of different opioid agonists on alkaline phosphatase and osteocalcin secretion by these cells. Neuroendocrinology 72:187–194
Ensrud KE, Blackwell T, Mangione CM, Bowman PJ, Bauer DC, Schwartz A, Hanlon JT, Nevitt MC, Whooley MA (2003) Central nervous system active medications and risk for fractures in older women. Arch Intern Med 163:949–957
Kinjo M, Setoguchi S, Schneeweiss S, Solomon DH (2005) Bone mineral density in subjects using central nervous system-active medications. Am J Med 118:1414
Pedrazzoni M, Vescovi PP, Maninetti L, Michelini M, Zaniboni G, Pioli G, Costi D, Alfano FS, Passeri M (1993) Effects of chronic heroin abuse on bone and mineral metabolism. Acta Endocrinol (Copenh) 129:42–45
Kim TW, Alford DP, Malabanan A, Holick MF, Samet JH (2006) Low bone density in patients receiving methadone maintenance treatment. Drug Alcohol Depend 85:258–262
Mora S, Zamproni I, Zuccotti G, Vigano A (2010) Pediatric HIV infection and bone health: an emerging challenge. Front Biosci (Elite Ed) 2:1265–1274
Warriner AH, Mugavero MJ (2010) Bone changes and fracture risk in individuals infected with HIV. Curr Rheumatol Rep 12:163–169
Mallon PW (2010) HIV and bone mineral density. Curr Opin Infect Dis 23:1–8
Pollock E, Klotsas AE, Compston J, Gkrania-Klotsas E (2009) Bone health in HIV infection. Br Med Bull 92:123–133
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders TR. American Psychiatric Association, Washington
Milos G, Spindler A, Ruegsegger P, Seifert B, Muhlebach S, Uebelhart D, Hauselmann HJ (2005) Cortical and trabecular bone density and structure in anorexia nervosa. Osteoporos Int 16:783–790
Freeman GH, Halton JH (1951) Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 38:141–149
Reddy RG, Aung T, Karavitaki N, Wass JA (2010) Opioid induced hypogonadism. BMJ 341:c4462
Merza Z (2010) Chronic use of opioids and the endocrine system. Horm Metab Res 42:621–626
Vuong C, Van Uum SH, O’Dell LE, Lutfy K, Friedman TC (2010) The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 31:98–132
Gordon CM, Nelson LM (2003) Amenorrhea and bone health in adolescents and young women. Curr Opin Obstet Gynecol 15:377–384
Gordon CM (2010) Clinical practice. Functional hypothalamic amenorrhea. N Engl J Med 363:365–371
Meczekalski B, Podfigurna-Stopa A, Genazzani AR (2010) Hypoestrogenism in young women and its influence on bone mass density. Gynecol Endocrinol 26:652–657
Berg KM, Kunins HV, Jackson JL, Nahvi S, Chaudhry A, Harris KA Jr, Malik R, Arnsten JH (2008) Association between alcohol consumption and both osteoporotic fracture and bone density. Am J Med 121:406–418
Wosje KS, Kalkwarf HJ (2007) Bone density in relation to alcohol intake among men and women in the United States. Osteoporos Int 18:391–400
Vestergaard P, Mosekilde L (2003) Fracture risk associated with smoking: a meta-analysis. J Intern Med 254:572–583
Vestergaard P, Rejnmark L, Mosekilde L (2006) Fracture risk associated with the use of morphine and opiates. J Intern Med 260:76–87
Wilczek H, Stepan J (2003) Bone metabolism in individuals dependent on heroin and after methadone administration (in Czech). Cas Lek Cesk 142:606–608
Amorosa V, Tebas P (2006) Bone disease and HIV infection. Clin Infect Dis 42:108–114
Lin D, Rieder MJ (2007) Interventions for the treatment of decreased bone mineral density associated with HIV infection. Cochrane Database Syst Rev:CD005645
Soussignan R, Jiang T, Rigaud D, Royet JP, Schaal B (2010) Subliminal fear priming potentiates negative facial reactions to food pictures in women with anorexia nervosa. Psychol Med 40:503–514
Misra M, Aggarwal A, Miller KK, Almazan C, Worley M, Soyka LA, Herzog DB, Klibanski A (2004) Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics 114:1574–1583
King AC, Canada SA (2004) Client-related predictors of early treatment drop-out in a substance abuse clinic exclusively employing individual therapy. J Subst Abuse Treat 26:189–195
Acknowledgements
The authors thank kindly the participants of the study.
Conflict of interest
The authors have stated that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Gabriella Milos, Luigi M. Gallo equally contributed to this work.
The authors have stated that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Milos, G., Gallo, L.M., Sosic, B. et al. Bone Mineral Density in Young Women on Methadone Substitution. Calcif Tissue Int 89, 228–233 (2011). https://doi.org/10.1007/s00223-011-9510-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-011-9510-4